Latest Conference Articles

With many new drug discoveries and medical devices int he field of advanced heart failure, Larry Allen, MD, MHS and his team are working to create patient decision support tools to help them navigate any challenges.

For 30 years, an outreach group in Oakland, CA has been winning the confidence of prostitutes as the first step in helping them be healthy and HIV-free. California Prostitutes Education Project representatives offered tips in a workshop.

Bonus video: As the 20th Annual US Conference on AIDS wound down, one presenter stood out—not just for advocacy work. She also sings. Here’s the conclusion of our interview with Adriana Garriga-Lopez, PhD, singing Manuel de Falla's "Nana".

Experts need to think about public health in a smarter way; it shouldn't just be about emergency management.

When talking about HIV, you're not just talking about one thing; you're talking about many different epidemics.

Exploring the HIV/AIDS epidemic in Puerto Rico, Adriana Garriga-Lopez, PhD, questioned how colonialism manifests on an every day level.

One of the late breaking studies at ECTRIMS 2016 looked at how 25OH vitamin D (25OHVitD) and smoking influences disability in patients with MS.

Researchers have evaluated siponimod's efficacy in treating secondary progressive multiple sclerosis (SPMS) in a phase 3 trial.

At the moment the best way to get a diagnosis of multiple sclerosis is through a brain scan. A team in Tennessee is working to improve that with a blood test that could find the condition sooner allowing for treatment to begin faster.

As the leading minds in the field of multiple sclerosis came together in London for the annual ECTRIMS conference the end of the conference brought a considerable amount of excitement in everything from the relapsing form to progressive forms.

As more and more treatments are approved for patients with multiple sclerosis questions are being answered about their effectiveness long past their approval dates. This is true for many of the medications including lemtrada.

A high percentage of people with HIV are also cigarette smokers, a problem that the state of Michigan is tackling with targeting smoking cessation programs.

People living with HIV/AIDS may have trouble getting authorization for HCV direct acting antivirals. Amida Care in NYC, a Medicai MCO came up with a plan.

Previous research has shown that prolonged-release fampridine (PR-FAM) can help walking ability in patients with multiple sclerosis (MS), however, it’s unclear whether those findings are clinically significant.

Are patients worse off if they are diagnosed with multiple sclerosis at a younger age? That’s what Italian researchers aimed to make more clear at ECTRIMS 2016.

The fight against HIV is not just a fight against a virus.

Social and religious conservatism appears to have turned the Southern US into the epicenter of the AIDS epidemic in the US, human rights activist Megan McLemore, JD, LLM said at a session on AIDS in the South today at the United States Conference on AIDS. Still another problem is the non-acceptance of LGBT people by many African-American churches, attendees added.

While neurologists may be able to successfully diagnose progressive multifocal leukoencephalopathy it may take a more specialized health care professional to effectively treat the condition.

“Multiple sclerosis usually begins with a relapsing-remitting (RRMS) phase characterized by clinical relapses and inflammatory demyelination evident on magnetic resonance imaging (MRI),” an Ohio based team began at ECTRIMS 2016.

Multiple sclerosis is perceived differently by the patient and physician – after all, they’re in two different boats. However, this disconnect could make managing the disease a more complicated journey.

"It's great that we have more tools for HIV prevention, but we should also work on the conditions that put people at risk."

AIDS activists have not lost their zeal for protest. At a pharma-sponsored luncheon, a band of activists criticizing the price of antivirals brought things to a brief halt.

Despite the development in HIV/ADIS research, "We are not close to where we should be or where we'd like to be," shared Carlos Rodriguez Diaz, PhD, University of Puerto Rico.

WIth high rates of HIV infection among black and Latino men who have sex with men, a dozen cities in the US have started trial programs aimed at getting HIV negative MSM to embrace pre-exposure prophylaxis, both "holistic" and pharmaceutical.

Unlike conditions like multiple sclerosis where there is a considerable amount of knowledge and several available approved treatment options that is not the case for neuromyelitis optica. As a result more work is needed to educate patients about what their treatment will be like.

There are currently no medications approved for the treatment of neuromyelitis optica. However, there are clinical trials underway and more research being done to change that in the coming years.

Ending this epidemic isn't just about stopping HIV, it's about really giving value and respect to sexual health and sexual well being.

With multiple medications approved to treat multiple sclerosis there is more work being done to help a larger patient population through the course of disease treatment.

It has been a few years now since Tecfidera was approved by the US Food and Drug Administration. In that time there has bee continued research which has shown positive results for patients.

HIV isn't just an issue of health or public health; rather, HIV is a magnifying glass to a myriad of social justice and human rights challenges that will not go away even if we end HIV.